We are live on ! Find out more
PAHC icon

Phibro Animal Health

91 hedge funds and large institutions have $555M invested in Phibro Animal Health in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 7

48% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 23

42% more capital invested

Capital invested by funds: $391M → $555M (+$163M)

28% more funds holding

Funds holding: 7191 (+20)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
91
Holders Change
+20
Holders Change %
+28.17%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
34
Reduced
23
Closed
7
Calls
$13K
Puts
Net Calls
+$13K
Net Calls Change
-$9K
Name Holding Trade Value Shares
Change
Change in
Stake
EI
26
EAM Investors
California
$3.77M +$3.3M +119,483 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.73M +$1.64M +59,233 +100%
SCM
28
Suffolk Capital Management
New York
$3.56M +$711K +25,702 +29%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$3.4M +$2.98M +107,700 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$2.98M -$128K -4,636 -5%
AI
31
Axiom Investors
Connecticut
$2.97M +$2.6M +94,130 New
Bank of America
32
Bank of America
North Carolina
$2.96M -$115K -4,171 -4%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$2.6M +$2.28M +82,500 New
SIM
34
Spark Investment Management
New York
$2.58M +$1.84M +66,400 +428%
BlackRock
35
BlackRock
New York
$2.48M +$19.4K +700 +0.9%
Charles Schwab
36
Charles Schwab
California
$2.37M +$1.18M +42,552 +131%
GIPM
37
G2 Investment Partners Management
New York
$2.36M +$828K +29,953 +67%
RFC
38
Russell Frank Company
Washington
$2.13M +$1.94M +70,274 +36,601%
TC
39
TFS Capital
Pennsylvania
$2.07M +$1.81M +65,507 New
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$1.97M +$1.59M +57,527 +1,186%
BIM
41
BlackRock Investment Management
Delaware
$1.92M -$8.6K -311 -0.5%
Citadel Advisors
42
Citadel Advisors
Florida
$1.76M +$402K +14,530 +35%
TCIM
43
TIAA CREF Investment Management
New York
$1.62M -$30.7K -1,109 -2%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.25M
JP Morgan Chase
45
JP Morgan Chase
New York
$1.16M -$69.1K -2,500 -6%
MAA
46
Managed Account Advisors
New Jersey
$1.08M +$555K +20,063 +142%
Invesco
47
Invesco
Georgia
$1.01M -$443K -16,021 -33%
MSTVIM
48
Messner & Smith Theme Value Investment Management
California
$948K +$831K +30,032 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$857K +$3.21K +116 +0.4%
CS
50
Credit Suisse
Switzerland
$837K +$734K +26,531 New

PAHC Hedge Fund Activity: Q4 2014 in Review

91 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2014, worth a combined $555M — up 42% from $391M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PAHC positions and 7 closed out — a net gain of 22 holders — while 34 added to existing stakes and 23 trimmed.

The largest buyer was Allianz Asset Management, adding an estimated $16.1M. The largest seller was 3I Investments, cutting an estimated $26M.

  • 91 institutional investors held Phibro Animal Health (PAHC) as of Q4 2014, up from 71 in Q3 2014.
  • Funds reported $555M of Phibro Animal Health stock for Q4 2014, up 42% quarter-over-quarter.
  • 29 funds opened new Phibro Animal Health positions in Q4 2014 and 7 closed out, a net change of +22 holders.
  • The largest Phibro Animal Health buyer in Q4 2014 was Allianz Asset Management, an estimated $16.1M added.
  • The largest Phibro Animal Health seller in Q4 2014 was 3I Investments, an estimated $26M sold.

Based on aggregated 13F filings for Q4 2014.